Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/12/2025

Pediatric Migraine Management

Introduction to Pediatric Migraine

  • Pediatric migraine is a common condition that requires proper management, including referral to specialist care when necessary, with guidelines supported by the American Academy of Neurology (AAN) 1

Referral to Specialist Care

  • Referral to specialist care is recommended when acute medication provides insufficient pain relief in children and adolescents, children have frequent or disabling headaches requiring preventive treatment, or medication overuse is present (Level B evidence), as suggested by the American Academy of Neurology 1, 2
  • Early referral to specialists is crucial for children with frequent or disabling migraines to avoid delayed referral and cycling through multiple ineffective treatments 1

Specialist Qualifications and Approach

  • Pediatric neurosurgeons and migraine specialists are trained to manage neurological conditions in children, with board certification and specialized training, and are available in major metropolitan areas 3, 1
  • A structured approach to pediatric migraine management includes detailed headache assessment and diagnosis using International Headache Society criteria (Level B evidence) 1

Diagnostic and Treatment Approaches

  • A detailed headache assessment and diagnosis using International Headache Society criteria is recommended, including assessment of headache frequency, severity, and disability (Level B evidence) 1
  • First-line acute treatments for pediatric migraines include ibuprofen for children and adolescents (Level B evidence), and consideration of triptans, such as nasal spray formulations of sumatriptan and zolmitriptan, for adolescents 1, 2
  • Preventive treatment options for pediatric migraines include amitriptyline combined with cognitive behavioral therapy, topiramate, and propranolol, although their effectiveness in children has not been definitively proven in clinical trials 1, 2

Neuroimaging

  • Neuroimaging has limited value in children with primary headaches, with only about 1% of children with headaches having relevant findings on MRI that explain their headaches, according to the American College of Radiology 4
  • Neuroimaging should be reserved for children with concerning neurological signs or symptoms 4

Best Practices

  • Lifestyle modifications and behavioral approaches should be emphasized alongside medication to avoid ignoring non-pharmacologic approaches 1
  • Specialists can help identify and manage medication overuse headaches, which are common in pediatric migraine patients 1
  • OnabotulinumtoxinA (Botox) should be reserved as a last-resort treatment for adolescents (generally 12+ years) with chronic migraine who have failed multiple conventional treatments, as it remains an off-label use in patients under 18 years of age 5, 2, 6

Treatment of Chronic Migraine

  • Chronic migraine is defined as ≥15 headache days per month for at least 3 months, and treatment options include preventive medications and lifestyle modifications 6
  • The American Academy of Neurology (AAN) guidelines and VA/DoD clinical practice guidelines suggest onabotulinumtoxinA injection for the prevention of chronic migraine in adults, but make no specific recommendations for pediatric populations 5, 6